Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

QURE stock hub

uniQure N.V. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

QUREis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

QURE

In the news

Latest news · QURE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-228.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-164.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All QURE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001590560
Company name	uniQure N.V.
Country	Netherlands
Country code	US
Cusip	N90064101
Employees	221
Employees Change	12%
Employees Change Percent	5.74
Enterprise value	$1.7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2007-06-20
Isin	NL0010696654
Last refreshed	2026-05-10
Market cap	$1.7B
Market cap category	Small-Cap
Price	$27.66
Price currency	USD
Rev Per Employee	81,868.78x
Sector	Healthcare
Sic	2834
Symbol	QURE
Website	https://www.uniqure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.98%
EV Sales Forward	52.61x
EV/Sales	94.1x
FCF yield	-9.9%
P/B ratio	11.67x
P/S ratio	96.36x
PS Forward	53.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-111.1M
Net Income	$-208.9M
Net Income Growth Years	2%
Pretax Margin	-1,123.34%
Profit Per Employee	$-945,109
ROA	-16.41
Roa5y	-6.23
ROCE	-25.26
ROE	-228.2
Roe5y	-96.19
ROIC	-164.2
Roic5y	-48.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.65%
Cagr1y	175.14%
Cagr3y	9.05%
Cagr5y	-3.2%
EPS Growth Years	2
Revenue Growth	-10.44x
Revenue Growth Q	127.31x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	-45.21x
Revenue Growth5 Y	-13.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.03
Assets	$778.7M
Cash	$586.6M
Current Assets	$615.7M
Current Liabilities	$59.2M
Debt	$545.7M
Debt Equity	$3.65
Equity	$149.3M
Interest Coverage	-2.98
Liabilities	$629.4M
Long Term Assets	$163M
Long Term Liabilities	$570.2M
Net Cash	$40.9M
Net Cash By Market Cap	$2.35
Net Debt Equity	$-0.27
Tangible Book Value	$54.5M
Tangible Book Value Per Share	$0.87
WACC	8.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.4
Net Working Capital	$-27M
Quick ratio	9.97
Working Capital	$556.5M
Working Capital Turnover	$0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.23%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	129.16%
1Y total return	174.95%
200-day SMA	25.67
3Y total return	29.68%
50-day SMA	16.84
50-day SMA vs 200-day SMA	50under200
5Y total return	-15.02%
All Time High	82.49
All Time High Change	-66.47%
All Time High Date	2019-06-20
All Time Low	3.73
All Time Low Change	641.55%
All Time Low Date	2024-07-05
ATR	1.98
Beta	0.87
Beta1y	0.65
Beta2y	1.37
Ch YTD	15.59
High	29.49
High52	71.5
High52 Date	2025-10-28
High52ch	-61.31%
Low	23.49
Low52	8.73
Low52 Date	2026-03-03
Low52ch	216.84%
Ma50ch	64.29%
Premarket Change Percent	0.83
Premarket Price	$24.35
Premarket Volume	16,165
Price vs 200-day SMA	7.76%
RSI	77.33
RSI Monthly	54.25
RSI Weekly	56.79
Sharpe ratio	1.08x
Sortino ratio	3.58
Total Return	-20.23%
Tr YTD	15.59
Tr1m	61.38%
Tr1w	44.59%
Tr3m	7.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	8
Analyst Price Target Top	$50.86
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.78
Earnings Revenue Estimate	4,981,368x
Earnings Revenue Estimate Growth	217.89x
Operating Income	$-181.7M
Operating margin	-1,004.4
Price target	$43.83
Price Target Change	$58.46
Price Target Change Top	$83.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,862,681%
Float Percent	79.11%
Shares Insiders	1.46%
Shares Institutions	80.51%
Shares Out	63,033,249
Shares Qo Q	0.6%
Shares Yo Y	20.23%
Short Float	22.26%
Short Ratio	6.2
Short Shares	17.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-190.9M
Average Volume	1,938,149.85x
Bv Per Share	2.37
CAPEX	$-453,000
Ch10y	129.2
Ch1m	61.38
Ch1w	44.59
Ch1y	175
Ch3m	7.84
Ch3y	29.68
Ch5y	-15.02
Ch6m	-0.47
Change	14.53%
Change From Open	13.83
Close	24.15
Days Gap	0.62
Depreciation Amortization	13,188,000
Dollar Volume	185,838,605.8
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$-181.7M
EBITDA	$-168.5M
EPS	$-3.49
F Score	2
FCF	$-172.6M
FCF EV Yield	-10.14x
FCF Per Share	$-2.74
Financing CF	335,278,000
Fiscal Year End	December
Founded	1,998
Goodwill	24,811,000
Income Tax	$5.6M
Investing CF	-243,158,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	27.3
Ma150ch	1.32%
Ma20	19.19
Ma20ch	44.17%
Net CF	-77,121,000
Next Earnings Date	2026-07-28
Open	24.3
Optionable	Yes
Position In Range	69.5
Post Close	27.66
Postmarket Change Percent	2.31
Postmarket Price	$28.3
Ppne	24,275,000
Pre Close	24.15
Price Date	2026-05-08
Ptbv Ratio	31.97
Relative Volume	3.47x
Revenue	18,093,000x
SBC By Revenue	101.47x
Share Based Comp	18,359,000
Tax By Revenue	31.08x
Tr6m	-0.47%
Volume	6,718,677

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does QURE pay a dividend?

Capital-return profile for this ticker.

Performance

QURE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns QURE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.5%

Float: +79.1% of shares outstanding

Insider ownership

+1.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

QURE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

77.3

Above 70: short-term overbought

Price vs 200-day MA

+7.8%

50/200-day relationship not available

Beta (5Y)

0.87

Moves roughly with the market

Sharpe ratio

1.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About QURE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current QURE stock rating?

uniQure N.V. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full QURE analysis?

The full report lives at /stocks/QURE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for QURE?

The latest report frames QURE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the QURE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.